Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with a lower risk of all-cause mortality compared with patients without SVR, according to a study in the Dec. 26 issue of JAMA.
Sustained Virological Response Linked with Improved Survival for Patients with Chronic HCV Infection
Comments
- Comments
Similar Articles
- Shifting the Balance of Power in Chronic Viral Infection
- Measuring Genomic Response to Infection Leads to Earlier, Accurate Diagnoses
- Antiretroviral Regimen Associated With Less Virological Failure Among HIV-Infected Children
- Zinc Helps Against Infection by 'Tapping the Brakes' in Immune Response
- Tactics of Novel Coronavirus Suggest Treatment by Altering Lung Cells' Response to Infection
Latest Articles
- A Collaborative Innovative Approach to Hand Hygiene: Tackling Contaminated Hands of Healthcare Providers and Patients
- Patient Characteristics Discriminate Between Asymptomatic and Symptomatic E. coli Bacteriuria
- Researchers Test Implementation of WHO Hand Hygiene Improvement Strategy in Critical Care Units
- PURELL Advanced Hand Sanitizer Receives Travelers Choice Award from TripAdvisor
- DebMed Announces U.S. Patent
Video Snapshot
Subscribe
Infection Control Today
